Device Week: COVID-19 Impact On J&J In Q1 2020; Dexcom, Abbott CGMs Make Way Into Hospitals
In this week's podcast, Medtech Insight’s Reed Miller discusses the impact of COVID-19 on Johnson & Johnson’s medical device businesses in Q1 2020. And Marion Webb explains Abbott and Dexcom's plans to bring continuous glucose monitoring devices directly to hospitals for remote monitoring of COVID-19 patients.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: